General MedicationsORALGeneric
VIDEX
DIDANOSINE
Standard Dose
100MG/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview VIDEX is listed in Drugs@FDA under application 020155 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength FOR SOLUTION;ORAL - 100MG/PACKET Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2006-11-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview VIDEX is listed in Drugs@FDA under application 020155 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength FOR SOLUTION;ORAL - 100MG/PACKET Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2006-11-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.